WEBULL
News
CVALF
1.350
NaN%
--
Covalon Technologies Ltd. to Release Q4 and Year-End Financial Results and Host Conference Call
Reuters · 1d ago
COVALON TECHNOLOGIES LTD - SPECIAL CASH DIVIDEND OF C$0.15 PER SHARE
Reuters · 11/19 22:30
Covalon Technologies Ltd. announces C$0.15 per share special dividend
Reuters · 11/19 22:30
Covalon Technologies Ltd. declares CAD 0.15 dividend
Seeking Alpha · 10/21 11:45
COVALON TECHNOLOGIES LTD - SPECIAL DIVIDEND OF $4.1 MLN CAD TO BE PAID NOV 18, 2025
Reuters · 10/21 11:00
Covalon Technologies Ltd. to Showcase Patient Safety Solutions at ANCC National Magnet & Pathway to Excellence Conference
Reuters · 10/07 11:00
Covalon Presents Evidence-Backed Innovations Making a Difference for Critically Ill Children at APHON
Barchart · 09/25 06:00
Covalon Technologies Appoints Abe Schwartz as New Chair Following Amir Boloor's Departure
Reuters · 09/23 21:00
COVALON TECHNOLOGIES LTD - AMIR BOLOOR STEPS DOWN AS EXECUTIVE CHAIR OF COVALON
Reuters · 09/23 21:00
Covalon Technologies Ltd. Set to Showcase Innovations at the Association for Vascular Access Annual Meeting
Reuters · 09/18 11:00
Evidence-Driven Outcomes and Clinical Innovation Highlight Covalon’s Presence at the Association for Vascular Access 2025 Annual Meeting
Barchart · 09/18 06:00
Covalon Technologies Announces New Clinical Study Showing 78% Reduction in CLABSI Rates with VALGuard® Line Guard
Reuters · 09/16 11:00
Weekly Report: what happened at CVALF last week (0908-0912)?
Weekly Report · 09/15 09:47
Weekly Report: what happened at CVALF last week (0901-0905)?
Weekly Report · 09/08 09:49
Weekly Report: what happened at CVALF last week (0825-0829)?
Weekly Report · 09/01 09:46
Weekly Report: what happened at CVALF last week (0818-0822)?
Weekly Report · 08/25 09:50
Covalon Technologies GAAP EPS of $0.00, revenue of $8.4M
Seeking Alpha · 08/21 11:01
Covalon Technologies Ltd. Reports 10.4% Revenue Growth to $8.4 Million and 52% Increase in Adjusted EBITDA for Fiscal Q3 2025
Reuters · 08/21 11:01
BRIEF-Covalon Q3 Adjusted Gross Margin 53.9%
Reuters · 08/21 11:00
COVALON REPORTS STRONG SEQUENTIAL QUARTER ON QUARTER AND TRAILING TWELVE MONTHS PERFORMANCE
Reuters · 08/21 11:00
More
Webull provides a variety of real-time CVALF stock news. You can receive the latest news about Covalon Technologies Ltd through multiple platforms. This information may help you make smarter investment decisions.
About CVALF
Covalon Technologies Ltd. is a Canada-based patient-driven medical device company that provides healthcare solutions for advanced wound care, infection control, and medical device coatings. The Company's solutions are designed for patients and made for care providers. The Company leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon's name, and by developing and commercializing medical products for other medical companies under development and license contracts. The Company has three proprietary platform technologies that have the potential to be developed into a number of medical devices and products: Collagen matrix, Antimicrobial silicone adhesive and Medical coatings. Its product type includes advanced wound care, antimicrobial dressings, collagen dressings, IV dressings, and perioperative dressings. Its brands include ColActive PLUS, CovaClear, CovaView, CovaWound, IV Clear, SurgiClear, and VALGuard.